The Consumer Care Division of Bayer HealthCare has launched Canesten Sensicare, the latest addition to Canesten’s worldwide product portfolio in this region.

The launch coincides with world renowned professor Andrew E Czeizel’s lecture tour of the Middle East on Canesten’s and Elevit superior research edge in healthy pregnancy and reduction of abnormalities in babies at birth, said a statement.

Prof Czeizel, is the world’s leading authority in the field of folic acid and birth defects prevention and has served as director of the WHO Collaborating Centre for the Community Control of Hereditary Diseases. 

He presented data and discussed findings on pre-term birth reduction after clotrimazole (Canesten) treatment during pregnancy in an exclusive lecture series for gynaecologists in Dubai on May 6 and in Beirut on May 7.

The findings, based on a study of 38,000 newborn infants, reveal that mothers who received clotrimazole during pregnancy including in the first trimester, showed a significant reduction in preterm births, said the statement.

Clotrimazole was registered in Germany for the first time in 1973 and launched in the market under the brand name Canesten. It advocates a proactive approach towards prevention of female yeast infection and its range of 36 products is marketed in more than 90 countries all over the globe, it said.

SensiCare is the latest intimate cleansing product containing lactic acid to maintain and support the natural balance and lotus extract for its calming and soothing properties. It is a preservative free, both gynaecologically and dermatologically tested formulation and proven to be hypoallergenic, said the statement.

Elevit is a prenatal supplement clinically proven to be beneficial for the development of a healthy baby. It is specifically formulated with the right level of vitamins, minerals and trace elements to help meet nutritional requirements during pregnancy and nursing, the statement said. – TradeArabia News Service